These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 16430194
1. Heptad-repeat-2 mutations enhance the stability of the enfuvirtide-resistant HIV-1 gp41 hairpin structure. Jenwitheesuk E, Samudrala R. Antivir Ther; 2005; 10(8):893-900. PubMed ID: 16430194 [Abstract] [Full Text] [Related]
3. Impact of the enfuvirtide resistance mutation N43D and the associated baseline polymorphism E137K on peptide sensitivity and six-helix bundle structure. Bai X, Wilson KL, Seedorff JE, Ahrens D, Green J, Davison DK, Jin L, Stanfield-Oakley SA, Mosier SM, Melby TE, Cammack N, Wang Z, Greenberg ML, Dwyer JJ. Biochemistry; 2008 Jun 24; 47(25):6662-70. PubMed ID: 18507398 [Abstract] [Full Text] [Related]
4. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses. Zhuang M, Vassell R, Yuan C, Keller PW, Ling H, Wang W, Weiss CD. J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30894471 [Abstract] [Full Text] [Related]
5. Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry. Yuan C, Wang JY, Zhao HJ, Li Y, Li D, Ling H, Zhuang M. Retrovirology; 2019 Dec 03; 16(1):36. PubMed ID: 31796053 [Abstract] [Full Text] [Related]
7. Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HR2) of gp41. Wang W, De Feo CJ, Zhuang M, Vassell R, Weiss CD. J Virol; 2011 Dec 03; 85(24):12929-38. PubMed ID: 21994458 [Abstract] [Full Text] [Related]
10. Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides. Lohrengel S, Hermann F, Hagmann I, Oberwinkler H, Scrivano L, Hoffmann C, von Laer D, Dittmar MT. J Virol; 2005 Aug 03; 79(16):10237-46. PubMed ID: 16051817 [Abstract] [Full Text] [Related]
11. Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients. Labrosse B, Morand-Joubert L, Goubard A, Rochas S, Labernardière JL, Pacanowski J, Meynard JL, Hance AJ, Clavel F, Mammano F. J Virol; 2006 Sep 03; 80(17):8807-19. PubMed ID: 16912327 [Abstract] [Full Text] [Related]
15. HIV-1 gp41 heptad repeat 2 (HR2) possesses an amino acid domain that resembles the allergen domain in Aspergillus fumigatus Asp f1 protein: review, hypothesis and implications. Becker Y. Virus Genes; 2007 Jun 03; 34(3):233-40. PubMed ID: 17333401 [Abstract] [Full Text] [Related]
20. Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART. Oliveira AC, Martins AN, Pires AF, Arruda MB, Tanuri A, Pereira HS, Brindeiro RM. AIDS Res Hum Retroviruses; 2009 Feb 03; 25(2):193-8. PubMed ID: 19239358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]